Drug recall · August 15, 2018
Diazepam Rectal Gel recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal delivery systems with lubricating jelly and instructions for use per carton, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807; Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215; NDC 68682-650-20.
- Lots / codes
Lot #: NBBN, Exp 02/22
- Quantity
- 306 cartons
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- Nationwide in the USA
- Initiated
- July 10, 2018 · Voluntary: Firm initiated
- Classified
- August 3, 2018
- Reported
- August 15, 2018
- Ended
- February 5, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.